Cyclo Therapeutics マネジメント
マネジメント 基準チェック /44
Cyclo Therapeutics' CEO is N. Fine, appointed in Sep 2015, has a tenure of 9.17 years. total yearly compensation is $672.89K, comprised of 80.4% salary and 19.6% bonuses, including company stock and options. directly owns 2.59% of the company’s shares, worth $536.73K. The average tenure of the management team and the board of directors is 7.3 years and 10 years respectively.
主要情報
N. Fine
最高経営責任者
US$672.9k
報酬総額
CEO給与比率 | 80.4% |
CEO在任期間 | 9.2yrs |
CEOの所有権 | 2.6% |
経営陣の平均在職期間 | 7.3yrs |
取締役会の平均在任期間 | 10yrs |
経営陣の近況
Recent updates
Cyclo Therapeutics GAAP EPS of -$0.41 beats by $0.12, revenue of $0.54M misses by $0.08M
Aug 16Here's Why We're A Bit Worried About Cyclo Therapeutics' (NASDAQ:CYTH) Cash Burn Situation
Jul 12We're A Little Worried About Cyclo Therapeutics' (NASDAQ:CYTH) Cash Burn Rate
Jan 20Cyclo Therapeutics: Addressing The Fundamentals Of Alzheimer's Disease
Nov 16Will Cyclo Therapeutics (NASDAQ:CYTH) Spend Its Cash Wisely?
Sep 28Cyclo therapeutics to join Russell 2000 Index
Jun 14We're Keeping An Eye On Cyclo Therapeutics' (NASDAQ:CYTH) Cash Burn Rate
Jun 12Cyclo Therapeutics posts design protocol of pivotal late-stage study of Trappsol Cyclo
Apr 27CEO報酬分析
日付 | 総報酬 | 給与 | 会社業績 |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$21m |
Mar 31 2024 | n/a | n/a | -US$19m |
Dec 31 2023 | US$673k | US$541k | -US$20m |
Sep 30 2023 | n/a | n/a | -US$19m |
Jun 30 2023 | n/a | n/a | -US$19m |
Mar 31 2023 | n/a | n/a | -US$18m |
Dec 31 2022 | US$1m | US$541k | -US$15m |
Sep 30 2022 | n/a | n/a | -US$13m |
Jun 30 2022 | n/a | n/a | -US$13m |
Mar 31 2022 | n/a | n/a | -US$13m |
Dec 31 2021 | US$1m | US$508k | -US$14m |
Sep 30 2021 | n/a | n/a | -US$14m |
Jun 30 2021 | n/a | n/a | -US$12m |
Mar 31 2021 | n/a | n/a | -US$10m |
Dec 31 2020 | US$489k | US$400k | -US$9m |
Sep 30 2020 | n/a | n/a | -US$9m |
Jun 30 2020 | n/a | n/a | -US$9m |
Mar 31 2020 | n/a | n/a | -US$8m |
Dec 31 2019 | US$490k | US$400k | -US$8m |
Sep 30 2019 | n/a | n/a | -US$6m |
Jun 30 2019 | n/a | n/a | -US$5m |
Mar 31 2019 | n/a | n/a | -US$5m |
Dec 31 2018 | US$467k | US$400k | -US$4m |
Sep 30 2018 | n/a | n/a | -US$4m |
Jun 30 2018 | n/a | n/a | -US$4m |
Mar 31 2018 | n/a | n/a | -US$4m |
Dec 31 2017 | US$441k | US$400k | -US$4m |
報酬と市場: N.'s total compensation ($USD672.89K) is about average for companies of similar size in the US market ($USD655.65K).
報酬と収益: N.'s compensation has been consistent with company performance over the past year.
CEO(最高経営責任者
N. Fine (67 yo)
9.2yrs
在職期間
US$672,888
報酬
Mr. N. Scott Fine has been Chief Executive Officer of Cyclo Therapeutics, Inc. (formerly known as CTD Holdings, Inc.) since September 14, 2015. Mr. Fine served as the Chairman of Cyclo Therapeutics, Inc. s...
リーダーシップ・チーム
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
CEO & Director | 9.2yrs | US$672.89k | 2.59% $ 536.7k | |
Founder & Director | no data | US$33.00k | 1.06% $ 220.4k | |
CFO & Secretary | 10.8yrs | US$463.98k | 0.059% $ 12.2k | |
Senior VP of Business Development & Chief Regulatory Officer | 5.3yrs | US$473.21k | 0.043% $ 8.9k | |
COO, Chief Quality Officer & Director | 9.2yrs | US$255.14k | 0.32% $ 66.4k | |
Global Head of Patient Advocacy | 3.5yrs | データなし | データなし | |
Interim Chief Medical Officer | 1.8yrs | データなし | データなし |
7.3yrs
平均在職期間
66yo
平均年齢
経験豊富な経営陣: CYTH's management team is seasoned and experienced (7.3 years average tenure).
取締役
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
CEO & Director | 10.8yrs | US$672.89k | 2.59% $ 536.7k | |
Founder & Director | 34.8yrs | US$33.00k | 1.06% $ 220.4k | |
COO, Chief Quality Officer & Director | 14.3yrs | US$255.14k | 0.32% $ 66.4k | |
Independent Director | 8.4yrs | US$40.13k | 0.47% $ 96.5k | |
Independent Chairman | 10.8yrs | US$66.38k | 1.21% $ 250.5k | |
Co-Chair of Scientific Advisory Board | no data | データなし | データなし | |
Co-Chairman of Scientific Advisory Board | 10yrs | US$600.09k | データなし | |
Independent Vice Chairman | 10.6yrs | US$41.25k | 1.22% $ 251.7k | |
Member of Scientific Advisory Board | 9.7yrs | データなし | データなし | |
Member of Scientific Advisory Board | 9.5yrs | データなし | データなし | |
Member of Scientific Advisory Board | 3.2yrs | データなし | データなし | |
Independent Director | 6.7yrs | US$35.63k | 0.44% $ 90.7k |
10.0yrs
平均在職期間
67yo
平均年齢
経験豊富なボード: CYTH's board of directors are seasoned and experienced ( 10 years average tenure).